Polymyalgia Rheumatica and Giant Cell Arteritis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Polymyalgia Rheumatica and Giant Cell Arteritis

Published:2020-09-08 Issue:10 Volume:324 Page:993
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Buttgereit Frank¹,Matteson Eric L.²,Dejaco Christian³⁴

Affiliation:

1. Charité University Medicine, Department of Rheumatology and Clinical Immunology, Berlin, Germany

2. Mayo Clinic College of Medicine and Science, Division of Rheumatology, Rochester, Minnesota

3. Medical University Graz, Department of Rheumatology and Immunology, Graz, Austria

4. Hospital of Brunico (SABES-ASDAA), Department of Rheumatology, Brunico, Italy

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2770392/jama_buttgereit_2020_it_200019_1599242807.07847.pdf

Reference9 articles.

1. Polymyalgia rheumatica and giant cell arteritis: a systematic review.;Buttgereit;JAMA,2016

2. Contemporary prevalence estimates for giant cell arteritis and polymyalgia rheumatica, 2015.;Crowson;Semin Arthritis Rheum,2017

3. Use of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis of polymyalgia rheumatica.;Henckaerts;Rheumatology (Oxford),2018

4. Diagnostic accuracy of positron emission tomography/computed tomography of the head, neck, and chest for giant cell arteritis.;Sammel;Arthritis Rheumatol,2019

5. Comparable rates of glucocorticoid-associated adverse events in patients with polymyalgia rheumatica and comorbidities in the general population.;Shbeeb;Arthritis Care Res (Hoboken),2018

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experience with olokizumab in the treatment of polymyalgia rheumatica and giant cell arteritis: A series of cases;Rheumatology Science and Practice;2024-09-03

2. Pharmacotherapy of giant cell arteritis and polymyalgia rheumatica: Prospects for the use of monoclonal antibodies to interleukin 6;Rheumatology Science and Practice;2024-09-02

3. Relevance of blood tumor markers in inpatients with significant involuntary weight loss and elevated levels of inflammation biomarkers;BMC Cancer;2024-04-15

4. Current Insights into Tissue Injury of Giant Cell Arteritis: From Acute Inflammatory Responses towards Inappropriate Tissue Remodeling;Cells;2024-02-29

5. Giant Cell Arteritis: Advances in Understanding Pathogenesis and Implications for Clinical Practice;Cells;2024-01-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3